IDEAYA Biosciences Inc —— 财务报表 (NASDAQ:IDYA) | MetaTrader

展开完整图表

新闻

Stocks Settle Higher in Hopes for an Agreement to End the Iran War

IDEAYA Biosciences, Inc. (IDYA) Discusses Topline Results from OptimUM-02 Trial Evaluating Darovasertib and Crizotinib in HLA-A2-Negative Metastatic Uveal Melanoma - Slideshow (NASDAQ:IDYA) 2026-04-13

Ideaya Biosciences: Stock Buoyant On Good mUM Data - But Approval Not A Formality (IDYA)

IDEAYA Biosciences, Inc. (IDYA) Discusses Topline Results from OptimUM-02 Trial Evaluating Darovasertib and Crizotinib in HLA-A2-Negative Metastatic Uveal Melanoma Transcript

Stocks Recover as Oracle Leads Software Companies Higher

Ideaya Biosciences Surges On Promising Results For Hard-To-Treat Melanoma

Stocks Retreat as US Set to Blockade the Strait of Hormuz

IDEAYA Eye Cancer Trial Data Beats Standard Therapy, Stock Soars - IDEAYA Biosciences (NASDAQ:IDYA)

Ideaya Biosciences Stock: Key Pivotal Data Imminent (NASDAQ:IDYA)

Truist重申Ideaya Biosciences股票评级,关注MTAP项目

Truist reiterates Ideaya Biosciences stock rating on MTAP program

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier